InMode Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: IL0011595993
USD
14.34
0.1 (0.7%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

413.65 k

Shareholding (Mar 2025)

FII

23.54%

Held by 150 FIIs

DII

49.24%

Held by 33 DIIs

Promoter

2.36%

How big is InMode Ltd.?

22-Jun-2025

As of Jun 18, InMode Ltd. has a market capitalization of 1,170.99 million, with net sales of 392.40 million and net profit of 175.78 million over the latest four quarters. As of Dec 24, shareholder's funds are 703.81 million and total assets are 785.67 million.

As of Jun 18, InMode Ltd. has a market capitalization of 1,170.99 million, categorizing it as a Small Cap company.<BR><BR>As of Jun 18, the sum of Net Sales for the latest four quarters is 392.40 million, while the sum of Net Profit for the same period is 175.78 million.<BR><BR>As of Dec 24, the reporting period shows Shareholder's Funds of 703.81 million and Total Assets amounting to 785.67 million.

Read More

What does InMode Ltd. do?

22-Jun-2025

InMode Ltd. is an Israeli company that develops and commercializes minimally-invasive surgical aesthetic and medical treatment solutions. As of March 2025, it reported net sales of $78 million and a net profit of $18 million, with a market cap of approximately $1.17 billion.

Overview: <BR>InMode Ltd. is an Israel-based company that designs, develops, manufactures, and commercializes energy-based, minimally-invasive surgical aesthetic and medical treatment solutions in the Pharmaceuticals & Biotechnology industry, classified as a small-cap company.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 78 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 18 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 1,170.99 Million (Small Cap)<BR><BR>Key Metrics: <BR>P/E: 7.00 <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.83 <BR>Return on Equity: 28.38% <BR>Price to Book: 1.89<BR><BR>Contact Details: <BR>Address: Tavor Building, Sha'ar Yokneam, Pob 533, YOKNEAM None: 2069200 <BR>Tel: ['972 4 9097470', '1 917 6078654']

Read More

Should I buy, sell or hold InMode Ltd.?

22-Jun-2025

Who are in the management team of InMode Ltd.?

22-Jun-2025

As of March 2022, the management team of InMode Ltd. includes Mr. Moshe Mizrahy as Chairman and CEO, Dr. Michael Kreindel as Chief Technology Officer, and independent directors Dr. Michael Anghel, Mr. Bruce Mann, and Dr. Hadar Ron.

As of March 2022, the management team of InMode Ltd. includes Mr. Moshe Mizrahy, who serves as the Chairman of the Board and Chief Executive Officer. Additionally, Dr. Michael Kreindel holds the position of Chief Technology Officer and Director. The board also features independent directors: Dr. Michael Anghel, Mr. Bruce Mann, and Dr. Hadar Ron.

Read More

Is InMode Ltd. overvalued or undervalued?

20-Sep-2025

As of July 30, 2025, InMode Ltd. has a very attractive valuation with a low P/E ratio of 7 and a PEG ratio of 0.40, but it has underperformed the S&P 500 with a year-to-date return of -9.16% and a 3-year return of -51.36%.

As of 30 July 2025, the valuation grade for InMode Ltd. has moved from attractive to very attractive, indicating a strong improvement in its valuation outlook. The company appears undervalued, supported by a P/E ratio of 7, a PEG ratio of 0.40, and an impressive ROCE of 103.34%. In comparison, its peer Sanmina Corp. has a significantly higher P/E ratio of 39.80, highlighting the relative attractiveness of InMode's valuation.<BR><BR>Despite its favorable valuation metrics, InMode has underperformed against the S&P 500 across multiple time frames, with a year-to-date return of -9.16% compared to the S&P 500's 12.22%. This performance, alongside a 3-year return of -51.36% versus the S&P 500's 70.41%, suggests that while the stock may be undervalued, market sentiment has not yet reflected this potential.

Read More

Is InMode Ltd. technically bullish or bearish?

28-Oct-2025

As of October 24, 2025, InMode Ltd. shows a neutral trend with mixed signals, as it has shifted from mildly bullish to sideways, underperforming the S&P 500 with a year-to-date return of -8.32% compared to the index's 15.47%.

As of 24 October 2025, the technical trend for InMode Ltd. has changed from mildly bullish to sideways. The current stance is neutral, with mixed signals across different indicators. The weekly MACD and KST are mildly bullish, while the daily moving averages indicate a mildly bearish trend. The Bollinger Bands show a mildly bullish signal on the weekly but a mildly bearish signal on the monthly. Dow Theory presents a mildly bearish view on the weekly but is mildly bullish on the monthly. <BR><BR>In terms of performance, InMode has underperformed the S&P 500 across multiple periods, with a year-to-date return of -8.32% compared to the S&P 500's 15.47%, and a one-year return of -13.5% versus 16.90% for the index.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

The company has declared negative results for the last 5 consecutive quarters

  • OPERATING CASH FLOW(Y) Lowest at USD 105.32 MM
  • DEBT-EQUITY RATIO (HY) Highest at -80.29 %
2

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 1,338 Million (Small Cap)

stock-summary
P/E

7.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.81

stock-summary
Return on Equity

28.44%

stock-summary
Price to Book

2.13

Revenue and Profits:
Net Sales:
96 Million
(Quarterly Results - Jun 2025)
Net Profit:
27 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-1.17%
0%
-1.17%
6 Months
-2.52%
0%
-2.52%
1 Year
-25.0%
0%
-25.0%
2 Years
-41.56%
0%
-41.56%
3 Years
-61.8%
0%
-61.8%
4 Years
-78.93%
0%
-78.93%
5 Years
-30.61%
0%
-30.61%

InMode Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
20.48%
EBIT Growth (5y)
18.98%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.83
Sales to Capital Employed (avg)
0.64
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
3,019.95%
ROE (avg)
30.67%
Valuation key factors
Factor
Value
P/E Ratio
7
Industry P/E
Price to Book Value
2.00
EV to EBIT
6.61
EV to EBITDA
6.56
EV to Capital Employed
6.83
EV to Sales
1.85
PEG Ratio
0.40
Dividend Yield
NA
ROCE (Latest)
103.34%
ROE (Latest)
28.38%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 99 Schemes (24.51%)

Foreign Institutions

Held by 150 Foreign Institutions (23.54%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 10.65% vs -36.52% in Jun 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 12.18% vs -57.27% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "95.60",
          "val2": "86.40",
          "chgp": "10.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "23.10",
          "val2": "18.50",
          "chgp": "24.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "26.70",
          "val2": "23.80",
          "chgp": "12.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "239.30%",
          "val2": "211.80%",
          "chgp": "2.75%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -19.76% vs 8.30% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -8.39% vs 22.54% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "394.80",
          "val2": "492.00",
          "chgp": "-19.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "113.30",
          "val2": "196.30",
          "chgp": "-42.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "181.30",
          "val2": "197.90",
          "chgp": "-8.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "285.00%",
          "val2": "397.60%",
          "chgp": "-11.26%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
95.60
86.40
10.65%
Operating Profit (PBDIT) excl Other Income
23.10
18.50
24.86%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
26.70
23.80
12.18%
Operating Profit Margin (Excl OI)
239.30%
211.80%
2.75%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is 10.65% vs -36.52% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 12.18% vs -57.27% in Jun 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
394.80
492.00
-19.76%
Operating Profit (PBDIT) excl Other Income
113.30
196.30
-42.28%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
181.30
197.90
-8.39%
Operating Profit Margin (Excl OI)
285.00%
397.60%
-11.26%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -19.76% vs 8.30% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -8.39% vs 22.54% in Dec 2023

stock-summaryCompany CV
About InMode Ltd. stock-summary
stock-summary
InMode Ltd.
Pharmaceuticals & Biotechnology
Inmode Ltd is an Israel-based company. It designs, develops, manufactures and commercializes energy-based, minimally-invasive surgical aesthetic and medical treatment solutions. The Company’s proprietary technologies are used by physicians to remodel subdermal adipose, or fatty, tissue in a variety of procedures including fat reduction with simultaneous skin tightening, face and body contouring and ablative skin rejuvenation treatments. Its products target a wide array of procedures including simultaneous fat killing and skin tightening, permanent hair reduction, skin appearance and texture, among others. The Company’s products may be used on a variety of body parts, including the face, neck, abdomen, upper arms, thighs and intimate feminine regions. It owns six product platforms: BodyTite, Optimas, Votiva, Contoura, Triton and EmbraceRF. All are market and sell traditionally to plastic and facial surgeons, aesthetic surgeons and dermatologists, among others.
Company Coordinates stock-summary
Company Details
Tavor Building, Sha'ar Yokneam, Pob 533 , YOKNEAM None : 2069200
stock-summary
Tel: 972 4 90974701 917 6078654
stock-summary
stock-summary
Registrar Details